Skip to content

Browse Protocols

Wrote one of these methods? Find yours by DOI and review the entry.

Find your method
934 protocols found
934 protocols found
GASTRIC
Publication-derived

Gastric Cancer Tumouroids (No. 2)

Source DOI

Duration: 7 days Cell source: Patient-Derived Gastric Cancer Tissue Full SOP · 7 phases · QC included
Drug screening
Full SOP with Academic or a plan
BRAIN
Publication-derived

Cerebral Malaria Brain Organoids (BN-DS-19)

Source Harbuzariu et al., 2019 · Morehouse School of Medicine, Department of Microbiology, Biochemistry and Immunology · DOI

Duration: 40 days Cell source: Human iPSC (CD34+ umbilical cord blood-derived) Full SOP · 10 phases · QC included
Disease modelling
BN-DS-19 Full SOP with Academic or a plan
BRAIN
Publication-derived

Bipolar Disorder Cerebral Organoids for Disease Modelling (BN-DS-20)

Source Kathuria et al., 2020 · Massachusetts General Hospital, Harvard Medical School · DOI

Duration: 270 days Cell source: Patient-Derived iPSC (Bipolar Disorder) Full SOP · 14 phases · QC included
Disease modelling
BN-DS-20 Full SOP with Academic or a plan
BRAIN
Publication-derived

Down Syndrome Cerebral Organoids for Disease Modelling (BN-DS-22)

Source Czerminski et al., 2022 · University of Massachusetts Medical School · DOI

Duration: 90 days Cell source: Patient-Derived iPSC (Down Syndrome, Trisomy 21) Full SOP · 8 phases · QC included
Disease modelling
BN-DS-22 Full SOP with Academic or a plan
PANCREAS
Publication-derived

Pancreatic Ductal Adenocarcinoma Tumouroids for Biobanking (PN-CA-19)

Source Driehuis et al., 2019 · Hubrecht Institute and University Medical Center Utrecht · DOI

Duration: 180 days Cell source: Patient-Derived tumor tissue from surgical resections and biopsies (pancreatic cancer, distal cholangiocarcinoma) Full SOP · 7 phases · QC included
Drug screening
PN-CA-19 Full SOP with Academic or a plan
BRAIN
Publication-derived

Congenital Cytomegalovirus Infection Cerebral Organoids (BN-DS-22)

Source O'Brien et al., 2022 · Medical College of Wisconsin · DOI

Duration: 44 days Cell source: Human iPSC Full SOP · 9 phases · QC included
Disease modelling
BN-DS-22 Full SOP with Academic or a plan
RETINA
Publication-derived

Retinal Degenerative Disease Organoids (RT-DS-25)

Source Galindo-Cabello et al., 2025 · University of Valladolid, Institute of Applied Ophthalmobiology (IOBA) · DOI

Duration: 150 days Cell source: Human iPSC, Human ESC Full SOP · 6 phases · QC included
Disease modelling
RT-DS-25 Full SOP with Academic or a plan
INTESTINAL
Publication-derived

Colorectal Cancer Colonic Organoids for Drug Screening (IN-CA-17)

Source Shimokawa et al., 2017 · Keio University School of Medicine · DOI

Duration: 180 days Cell source: Patient-Derived CRC (Colorectal Cancer) Organoids Full SOP · 10 phases · QC included
Drug screening
IN-CA-17 Full SOP with Academic or a plan
SKIN
Publication-derived

Localised Scleroderma Skin Organoids (SK-DS-22)

Source Ma et al., 2022 · Peking Union Medical College Hospital, Chinese Academy of Medical Sciences · DOI

Duration: 17 days Cell source: Human iPSC (Nuwacell RC01001-B) Full SOP · 7 phases · QC included
Disease modelling
SK-DS-22 Full SOP with Academic or a plan
LIVER
Publication-derived

Liver Organoids for Drug Screening (2025) (LV-DI-25)

Source Shin et al., 2025 · Korea Research Institute of Chemical Technology · DOI

Duration: 48 days Cell source: Human pluripotent stem cells (hPSCs) Full SOP · 10 phases · QC included
Drug screening
LV-DI-25 Full SOP with Academic or a plan
BRAIN
Publication-derived

Opioid Use Disorder Cortical Organoids for Disease Modelling (BN-DS-23)

Source Dwivedi et al., 2023 · University of California, San Diego · DOI

Duration: 120 days Cell source: Human iPSC Full SOP · 7 phases · QC included
Disease modelling
BN-DS-23 Full SOP with Academic or a plan
RETINA
Publication-derived

Retinal 2D Cell Cultures for Regenerative Medicine (RT-DS-14)

Source Reichman et al., 2014 · INSERM, Institut de la Vision, Université Paris Descartes · DOI

Duration: 21 days Cell source: Human iPSC Full SOP · 6 phases · QC included
Disease modelling
RT-DS-14 Full SOP with Academic or a plan
RETINA
Publication-derived

Retinal Organoids for Disease Modelling (2020, No. 2) (RT-DS-20)

Source Chichagova et al., 2020 · Institute of Genetic Medicine, Newcastle University · DOI

Duration: 180 days Cell source: Human iPSC Full SOP · 7 phases · QC included
Disease modelling
RT-DS-20 Full SOP with Academic or a plan
LUNG
Publication-derived

Influenza Airway Organoids for Infection Studies (AW-DS-18)

Source Zhou et al., 2018 · The University of Hong Kong, Department of Microbiology · DOI

Duration: 72 days Cell source: Adult stem cell-derived human airway organoids from normal lung tissue adjacent to resected diseased tissue Full SOP · 5 phases · QC included
Disease modelling
AW-DS-18 Full SOP with Academic or a plan
BRAIN
Publication-derived

Brain Organoids for Developmental Studies (2015) (BN-TX-15)

Source Sakaguchi et al., 2015 · RIKEN Center for Developmental Biology · DOI

Duration: 197 days Cell source: Human ESC Full SOP · 5 phases · QC included
Developmental biology
BN-TX-15 Full SOP with Academic or a plan
LIVER
Publication-derived

Fatty Liver Disease Organoids (2022) (LV-FI-22)

Source Hess et al., 2022 · Massachusetts General Hospital · DOI

Duration: 26 days Cell source: Human iPSC Full SOP · 9 phases · QC included
Disease modelling
LV-FI-22 Full SOP with Academic or a plan
BRAIN
Publication-derived

Huntington's Disease Cerebral Organoids (BN-DS-19)

Source Zhang et al., 2019 · Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research (A*STAR), Singapore · DOI

Duration: 28 days Cell source: Human ESC (isogenic Huntington Disease lines: 30Q, 45Q, 65Q, 81Q CAG repeats) and Human iPSC (18Q, 71Q, 109Q CAG repeats) Full SOP · 10 phases · QC included
Disease modelling
BN-DS-19 Full SOP with Academic or a plan
BRAIN
Publication-derived

Ischaemic Stroke Cerebral Organoids for Drug Screening (BN-DS-23)

Source Wang et al., 2023 · Second Military Medical University/Naval Medical University, Shanghai · DOI

Duration: 86 days Cell source: Human ESC (H1) Full SOP · 7 phases · QC included
Drug screening
BN-DS-23 Full SOP with Academic or a plan
LIVER
Publication-derived

Hepatitis C Liver Organ-on-Chip Models (LV-IF-21)

Source Natarajan et al., 2021 · The Gladstone Institutes, San Francisco, CA, USA · DOI

Duration: 4 days Cell source: Patient-Derived Adult Stem Cells (ASC), HCV spontaneous resolver CD8+ T cells Full SOP · 11 phases · QC included
Disease modelling
LV-IF-21 Full SOP with Academic or a plan
BRAIN
Publication-derived

Autism Spectrum Disorder Cortical Organoids (2023) (BN-DS-23)

Source Sarieva et al., 2023 · Hertie Institute for Clinical Brain Research, University of Tübingen · DOI

Duration: 90 days Cell source: Human iPSC Full SOP · 7 phases · QC included
Disease modelling
BN-DS-23 Full SOP with Academic or a plan
BRAIN
Publication-derived

High-Grade Meningioma Brain Organoids (BN-DS-23)

Source Huang et al., 2023 · Sun Yat-Sen University, Department of Neurosurgery, Xiangya Hospital, Central South University · DOI

Duration: 90 days Cell source: Patient-Derived Tumor (Meningioma) Full SOP · 9 phases · QC included
Drug screening
BN-DS-23 Full SOP with Academic or a plan
BRAIN
Publication-derived

Encephalopathy of Prematurity Cortical Organoids (BN-DS-19)

Source Paşca et al., 2019 · Stanford University School of Medicine · DOI

Duration: 120 days Cell source: Human iPSC Full SOP · 13 phases · QC included
Disease modelling
BN-DS-19 Full SOP with Academic or a plan
BRAIN
Publication-derived

Parkinson's Disease Midbrain Organoids for Drug Screening (BN-DS-22)

Source Jarazo et al., 2022 · Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine, University of Luxembourg · DOI

Duration: 30 days Cell source: Patient-Derived iPSC (PINK1 mutations) Full SOP · 17 phases · QC included
Drug screening
BN-DS-22 Full SOP with Academic or a plan
BRAIN
Publication-derived

Parkinson's Disease Midbrain Organ-on-Chip Models (BN-DS-19)

Source Bolognin et al., 2019 · Luxembourg Centre for Systems Biomedicine, University of Luxembourg · DOI

Duration: 42 days Cell source: Patient-Derived iPSC (Parkinson's disease, LRRK2-G2019S) Full SOP · 8 phases · QC included
Drug screening
BN-DS-19 Full SOP with Academic or a plan